A miniature glaucoma shunt intended as a less invasive alternative to trabeculectomy to reduce intraocular pressure in patients with glaucoma that has not responded well to medications and other surgical treatments.
Horizon Scanning
It is a challenge for health plans and clinicians to know what emerging technologies are in the preapproval phase and what their clinical, financial, and risk impacts might be. This is where we come in.The Hayes Horizon Scanning Solution identifies innovative and potentially disruptive health technologies that are in various stages of the regulatory approval process. Our Research Analysts continually investigate new technologies that are on the horizon or in the early stages of clinical investigation, as well as the testing of existing technologies that may be seeking approval for new clinical applications. Hayes Horizon Scanning helps you track emerging technologies before you need to make decisions. Accessed through the Hayes Knowledge Center, Hayes Horizon Scanning addresses the following fundamental questions to help our clients forecast emerging technologies:
- Is this emerging technology new or replacing an existing technology?
- Where is this technology in the FDA regulatory process?
- When will this technology be commercially available in the market?
- What is the projected use, cost, and financial impact of this technology?
Bryan® Cervical Disc System
An artificial cervical disc for treatment of single-level cervical degenerative disc disease in patients with radiculopathy and myelopathy, including those with disc herniation or spondylosis, whose condition has not responded to conservative treatments.